Summary
We report some properties of propionyl CoA carboxylase (PCC) partially purified from cultured human fibroblasts obtained from controls and several patients with propionic acidemia. A series of steps (Triton X-100 treatment, high speed centrifugation, ammonium sulfate precipitation, and density gradient centrifugation) led to 100-to 300-fold purification of control enzyme. Control PCC had a molecular weight of nearly 700,000, contained biotin, demonstrated a pH optimum at 8.0-8.5, was activated by potassium, and followed Michaelis-Menten kinetics for each of its substrates. It was distinguished from acetyl CoA carboxylase immunologically as well as by differential purification.
Each of seven lines from patients with propionic acidemia had clearly detectable PCC activity which was less than 5% of that in control lines. Although yields were poor and purification less extensive than in control lines, mutant PCC was enriched 2-to 40-fold by the same procedures employed for the control enzyme. Mutant enzyme had a pH optimum, ionic requirements, and substrate K, ' s similar to those of control PCC, but was distinctly more labile to both cold and heat. These findings suggest that the markedly reduced activity of PCC in these patients results from a mutation in the PCC structural gene locus or loci which leads to the synthesis of altered enzyme protein molecules. monemia (14) , and also have intermittent hyperglycinemia. The condition can be lethal in infancy and can produce seizures and severe brain damage. Some patients with severe PCC deficiency, however, have mild and even benign clinical manifestations (15, 20) .
Successful partial purification of PCC (100-to 300-fold) from cultured normal human skin fibroblasts has enabled us to define some of its biochemical properties. Comparison of these properties with those of PCC from cultured fibroblasts of patients with propionic acidemia has provided evidence that PCC deficiency in these patients results from the synthesis of a structurally altered enzyme (1 1).
MATERIALS AND METHODS
Propionyl CoA and acetyl CoA were prepared as described previously (lo), except that the propionic anhydride-coenzyme A solution was neutralized with sodium hydroxide to avoid contamination with potassium or bicarbonate. The anti-chick ACC antibody was a generous gift from Dr. Philip Majerus of Washington University, St. Louis, MO, avidin was purchased from General Biochemicals; urease, catalase, and thyroglobuli were purchased from Sigma Chemicals; other reagents were obtained as reported previously (10) .
Speculation

PATIENTS WITH PCC DEFICIENCY
Our results suggest that human propionyl CoA carbox~lase has A. G. (1, lo) , the sister of the first-described patient with "ketotic properties very similar to those of other mammalian propionyl hyperglycinemia~, has had attacks of ketoacidosis successfully COA carboxylases. Further chemical studies with control enzyme treated by diet, with normal physical and intellectual growth. R and that from patients with propionic acidemia may help define H., a girl, presented with ketoacidosis and failure to thrive. She the basis for the tW0 major genetic complementation groups had irreversible brain damage by the time p~c deficiency was reported among p r o~i o n~l CoA carbox~lase deficient patients. diagnosed at age 1 yr. G. S. (14) , a black male, whose older sister died in infancy of a similar clinical syndrome, had intermittent ketoacidosis complicated by severe hyperammonemia. He suffered PCC (propionyl CoA: COz lyase (ADP) EC 6.4.1.3) is a key from recurrent attacks of seizures and coma, had evidence of brain enzyme (7, 8, 12, (18) (19) (20) in the catabolic pathway for the three-damage, and died at the age of 4 yr. P. C. (14) , a girl, presented carbon residue from isoleucine, threonine, methionine, valine (26) , with ketoacidosis and moderate hyperammonemia. She had seibranched chain .and odd carbon fatty acids, cholesterol, and zures, attacks of coma, and died with irreversible acidosis at the thymine. It reversibly catalyzes the carboxylation of propionyl age of 2 yr. N. B. (IS), a moderately retarded girl with three CoA to D-methylmalonyl CoA which is isomerized to succinyl unaffected siblings, presented with seizures and hyperglycinemia CoA in two steps by methylmalonyl CoA racemase and methyl-at age 9 months. She exhibited no ketoacidosis or hyperammomalonyl CoA mutase (12) . PCC has been studied extensively in nemia unless given a high protein load. N. M. (20) a 4-year-old liver of ruminants (12, 18) , and in rat liver mitochondria (19) . In Mennonite boy with two clinically normal siblings, had hyperglyman, the activity of this enzyme has been measured in cultured cinemia associated with seizures and retardation, but no ketoacifibroblasts (lo), leukocytes (9), liver (3, 4, 17) , and amniotic fluid dosis. His 9-year-old sister, K. M., was entirely normal clinically, cells (5) . It has been purified 20-fold from human liver mitochon-yet had equally marked deficiency of PCC (20) . dria (4) .
The important role of this enzyme in human intermediary CULTURED FIBROBLASTS metabolism is evident from the dire consequences of inherited PCC deficiency. Patients with defective PCC activity have elevated Punch biopsies of the skin were obtained, with informed consent blood and urine propionate levels (24) , are susceptible to attacks and generally from the flexor surface of the forearm, from these of severe ketoacidosis, may develop hypoglycemia and hyperam-seven PCC-deficient patients and from eight normal adult volun-teers. The biopsies were cultured as reported previously (8, 20) . Between the 10th and 28th passages, cells were harvested at confluence by treatment with 0.25% trypsin and centrifugation at 110 x g. The cell pellets were resuspended and washed first in isotonic saline, pH 7.5, then in isotonic sucrose. Pellets were then processed immediately, or stored frozen at -68°C for up to 6 weeks.
ENZYME PURIFICATION
All purification steps were carried out at +4"C. Cells were broken by exposure to distilled water for 10 min, addition of 0.05 M Tris buffer, pH 7.5, containing 0.001 M EDTA, and gentle mechanical disruption with three strokes of a Potter-Elvehjem homogenizer. Unbroken cells and cell debris were removed by centrifugation at 250 x g for 15 min, retreated with distilled water as above, and centrifuged again at 250 X g. Reducea glutathione (GSH) was added to the combined supernatants to a concentration of 0.005 M, and the preparation was centrifuged at 118,000 x g for 120 min. The,pellet was resuspended in the above medium plus 0.3% (v/v) Triton X-100, and stirred for 30 mi n, it was then centrifuged at 10,000 x g for 20 min. A saturated ammonium sulfate solution was added to the supernatant with stirring over 60 rnin until 35% saturation was reached. This preparation was centrifuged at 10,000 x g for 30 min and the supernatant was brought to 50% saturation of ammonium sulfate. The preparation from control cells could be stored at this stage at -68°C for several weeks without loss of enzyme activity. Further purification was achieved by centrifuging the 50% ammonium sulfate suspension at 10,000 x g and redissolving the protein precipitate in 0.05 M Tris buffer (pH 7.5) containing 0.001 M EDTA, 0.005 M GSH, 0.1% (v/v) .Triton X-100, and 1 % (v/v) glycerol. The preparation was then dialyzed overnight against the same solution to remove ammonium sulfate. The dialyzed enzyme preparation was centrifuged at 450 x g for 10 min; 0.2-0.3 ml of the supernatant was layered over a 5 ml, 5-20% linear concentration gradient of sucrose (w/v) or glycerol (v/v) in the buffer mentioned above, and centrifuged at 130,000 x g for 4 hr in a Beckman (SW 50.1) swinging bucket rotor. Aliquots of 0.2 ml were collected from the gradient using an ISCO density gradient fractionator (Model 640). The three or four aliquots containing the bulk of the enzyme activity were pooled for biochemical studies.
CARBOXYLASE ASSAYS
PCC was assayed, as described previously, by measurement of [I4C] bicarbonate incorporation, in the presence of propionyl CoA, into a nonvolatile, "COz-futed" state (9) . The incubation mix contained 5% (v/v) glycerol, 1% (v/v) Triton X-100, 0.05 M Tris (pH 8.0), 0.005 M GSH, 0.002 M neutralized adenosine triphosphate (ATP), 0.01 M magnesium chloride, 0.025 M potassium chloride, 0.003 M propionyl CoA, and 0.01 M sodium ["Clbicarbonate (12.2 pCi/pmole), with 0.02-0.05 ml of the protein preparation, in a final volume of 0.1 ml. Incubation (37°C) was timed from addition of the ["Clbicarbonate and was terminated after 5-60 rnin by addition of 0.05 ml 10% trichloroacetic acid. All assays were in duplicate and included a blank containing no propionyl CoA. One unit of PCC activity is defmed as that catalyzing the formation of 1 nmole of product (or of futing 1 nrnole of COZ) qer minute, and specific activity (SA) is presented as units/mg protem.
Acetyl CoA carboxylase (ACC) activity was also estimated by incorporation of ["Clbicarbonate, in the presence of acetyl CoA and its allosteric activator, citrate, into either malonate or into a nonvolatile, COz-fied state (16) . Recovery of ["C]malonate in the presence of carrier malonate after ether extraction and paper chromatography (10) was 50% in the absence of citrate and 70% in the presence of citrate. Replicate portions of cell extracts were first incubated for 30 rnin at 37"C, with and without 0.01 M sodium citrate, in 0.03 M Tris (pH 7.6), 0.001 M EDTA, 0.01 M GSH, 0.01 M magnesium chloride, and 0.6 mg/ml bovine serum albumin. The reaction, in a final volume of 1.0 ml or 0.1 ml, was initiated by addition of 0.001 M ATP, 0.0015 M acetyl CoA, and 0.02 M sodium ["Clbicarbonate (4.5 pCi/pnole) and proceeded for 10 rnin at 37°C. The reaction was stopped by addition of alkali for [14C]malonate extraction (lo), or by addition of acid for COz futation (9, 16) . All assays were in duplicate and included a blank containing no acetyl CoA. SA was defined as PCC.
Protein determination by the standard Lowry procedure, as used previously (lo), was satisfactory for high protein concentrations in crude cell extracts. Because Tris buffer (21) and Triton X-100 (28) interfered with the Lowry reaction for the very low protein concentrations in the density gradient fractions, a fluorometric assay was used (27) with bovine serum albumin as the standard.
PROPERTIES OF PCC
For the Michaelis-Menten kinetic studies, the potassium concentration was maintained at 0.025 M, and one substrate was varied at a time. When bicarbonate was the variable substrate, the SA of ["Clbicarbonate was increased to 50 pCi/pmole at the lowest bicarbonate concentrations.
For thermostability experiments, 0.04 ml of cell extracts or partially purified preparations, in the final buffer, were transferred to preheated tubes in a water bath at the test temperature (37-58°C) for timed intervals (30 sec-60 min), then the tubes were removed and immersed in ice; control portions were retained in similar tubes in ice. PCC was then assayed by adding 0.06 ml of prewarmed reagent mixture to these (rewarmed) tubes for incubation at 37°C for 10 min.
Anti-ACC antibody, prepared against chick enzyme (1 p1 neutralized 2500 units of chick ACC activity at 25OC) (16) . was tested against 0.04 ml of protein preparations for its ability to inhibit PCC and ACC activity.
AVIDIN INHIBITION
Avidii inhibition of carboxylase activity was tested by preincubating 0.02 ml of the cell fractions with 0.02 ml of mixtures of avidin and biotin for 10 min at 37°C (1 U avidin inactivates 1 pg biotin), followed by adding 0.06 ml of the appropriate reagent .
mixture for assay of PCC or ACC activity. For ACC activity, avidin treatment was performed before the addition of citrate, avoiding the protective effect of citrate on avidin inhibition of ACC (23) .
RESULTS
CONTROL FIBROBLASTS
Partial Pur~cation. We observed initially that more PCC activity was found in cell extracts prepared by lyophilization than from preparations obtained by freeze-thawing, acetone precipitation, or sonication. As noted in the results of a representative experiment shown in Table 1 , treatment of the crude cell lysate from three roller bottles with the detergent, Triton X-100 , resulted in an approximately 2-fold increase in both specific activity and total enzyme activity. SA was increased 2-fold further in the pellet obtained after 118,000 x g centrifugation. Subsequent ammonium sulfate precipitation and density gradient centrifugation yielded an enzyme preparation purified 300-fold with a yield of 11%
As noted in Table 2 , purification of PCC from five different control lines gave similar, but not identical, results. Initial SA ranged from 0.34-1.42 U/mg; final SA from 53-175 U/mg. Overall purification ranged from 110-to 300-fold with yields from 11-17%.
Physical Properties of Partially Purifed PCC. Despite attempts to stabilize the enzyme by addition of 10% (w/v) bovine serum albumin, 1% (v/v) glycerol, 0.1 mg/ml biotin, or 0.003 M propionyl CoA, PCC activity from the peak density gradient fractions deteriorated markedly overnight at 4"C, thereby making it necessary to characterize this fraction on the day it was prepared. ' Results shown are representative of several experiments with a single control line.
Pooled PCC activity from four adjacent fractions. The molecular weight of the partially purified enzyme was estimated by density gradient centrifugation using urease (MW-483,000), catalase (MW-232,000) and porcine thyroglobulin (MW-669,000) as ,markers (2) . As noted in Figure 1 , sedimentation of PCC activity corresponded closely to that of thyroglobulin, a result in good agreement with the MW of 700,000 obtained previously for crystalline PCC from pig heart (12) .
Biochemical Properties of Partially PuriJied PCC. PCC activity in Fraction IV (see Table 1 ) was linear with time for 30 min and with protein content over the range employed. As expected, activity depended on the presence of propionyl CoA, ATP, and bicarbonate. Addition of potassium at concentrations of 0.01 M and above stimulated activity 10-fold. PCC activity revealed a broad pH optimum between 8.0 and 8.5, and neither glycerol, sucrose, Triton X-100, nor ammonium sulfate interfered.
As shown in Figure 2 , partially purified PCC demonstrated Michaelis-Menten kinetics for each of its substrates. At ATP concentrations greater than 0.020 M, activity was inhibited; substrate inhibition was not observed for propionyl CoA or bicarbonate. The estimated K,' s for the three substrates are as follows: propionyl CoA, 1.7 X M; bicarbonate, 4.5 X M; ATP, 0.9 x 10-3 M.
PCC was unstable to heating. Incubation of Fraction IV at temperatures above 50°C for 5 min resulted in marked loss of activity. At 54OC, the tm for activity loss was 15 min, at 5g°C, the tm was 3 min. PCC activity was even less stable in crude extracts, its tm at 54OC being 5 min.
Biotin-Avidin Interactions. Neither addition of biotin to the growth medium nor incubation of crude cell extracts or partially purified enzyme fractions with this cofactor enhanced PCC activity. As expected, incubation of crude extracts with avidin inhibited PCC activity markedly (Fig. 3) ; this inhibition was prevented by exposing the avidin to increasing amounts of biotin before incubating it with PCC fractions.
ACC Activity and Anti-ACC. ACC activity, defined as citrateactivated [14C]bicarbonate incorporated in the presence of acetyl CoA was present in crude cell lysates and in 118,000 X g pellets prepared from them (Table 3) ; it was undetectable in the 35-50% ammonium sulfate precipitate. Additional evidence that the ACC and PCC activities reflected the presence of different proteins came from antibody studies. Addition of specific anti-chick liver ACC antibody to a 118,000 x g pellet containing both ACC and PCC activities resulted in 55% loss of ACC activity, but no loss of PCC activity (Table 4) . Biotin (rg/mg protein) Fig. 3 . Effect of addition of avidin and/or biotin on PCC specific activity (units/mg protein) in crude lysates of control cells. One unit of avidin was added to some lysates (closed squares) 5 min before PCC assay. Biotin, in the amounts shown on the abscissa, was added to both avidintreated or avidin-untreated lysates 10 min before assay.
PCC DEFICIENT FIBROBLASTS
PCC Activity. Each of the seven cell limes from patients with propionic acidemia had much reduced PCC activity. Although considerable variation was noted. among preparations from the same cell line, crude extracts of these limes always had detectable PCC activity at values less than 5% of the control mean. This mutant cell activity was poorly preserved during storage. When crude extracts of control cells were kept at 4OC for up to 24 hr, no loss of PCC activity was noted; similar treatment of mutant cell extracts led to 70-90% loss of activity. Frozen cell pellets were no more stable. PCC activity in one mutant line decreased by 75% when intact cell pellets were stored at -20°C before lysis and assay. Therefore, all subsequent experiments with mutant cells were conducted with cells harvested immediately before use.
Partial Purijcation. As noted in Table 5 , the purification procedure employed for control limes was much less effective in recovering PCC activity from mutant cells. Triton X-100 treatment failed to increase PCC SA in crude lysates of mutant cells and led to some loss in total activity in two of the four lines examined (A. G. and G. S.). Although PCC activity from mutant cells was found in the same centrifugation fractions, ammonium sulfate cuts, and density gradient fractions as those in control cells, at each step, enrichment of activity and yield were much poorer than in control cells. Much of the loss took place before ammonium sulfate treatment, but omission of detergent treatment and high speed centrifugation before addition of ammonium sulfate gave no appreciable increase in purification or yield. Furthermore, addition of glycerol, bovine serum albumin, propionyl CoA, ATP, or biotin failed to increase PCC recovery. In the four mutant lines used, PCC SA after glycerol density gradient centrifugation ranged from 0.12-1.64 U/mg, reflecting only 2-to 40-fold purification. At this stage the yield was only 0.1-1.0% of starting activity.
Biochemical and Physical Properties. Many characteristics of the partially purified PCC in Fraction IV from mutant lines were indistinguishable from those for control enzyme. Thus, the mutant enzymes appeared to have the same molecular weight, pH optimum, and affinity for all three substrates as did control PCC. Furthermore, mutant PCC activity was not enhanced by addition of biotin to the growth medium, extraction buffers, or assay medium, and was, as in control preparations, inhibited markedly by prior exposure to avidin. Significantly, SA of ACC in mutant extracts was similar to that of controls, and addition of anti-ACC antibody failed to affect the residual PCC activity found in mutant lysates or fractions thereof.
The thermostability of mutant PCC was, however, consistently and distinctly reduced when compared to that of control enzyme at all temperatures studied above 50°C. These differences are shown most clearly in the time-dependent heating studies shown in Figure 4 . At 54OC, control and mutant PCC activity decayed with a tm of 3 and 0.5 min, respectively. Thermolability of mutant PCC was unaffected by addition'of appropriate enzyme substrates, biotin, glycerol, bovine serum albumin, or heat-inactivated control cell extracts.
DISCUSSION
In the early 1960's, PCC was purified to homogeneity from pig heart (12) and to near homogeneity from bovine liver (7, 8) . From this work, a distinct, yet still incomplete picture of the mammalian enzyme emerged. Mammalian PCC is a mitochondria1 protein with a molecular weight approximating 700,000. Because it contains four biotinyl prosthetic groups per molecule, and because other mammalian biotin-dependent enzymes have been shown to be oligomeric, it seems likely that PCC is composed of four protomers with one biotin residue per protomer. Although the precise subunit structure of the protomer and reaction mechanism remain obscure, PCC is activated by potassium ions and catalyzes the ATP-dependent carboxylation of propionyl CoA by a concerted mechanism which follows Michaelis-Menten kinetics for each of its substrates. The enzyme has a broad pH optimum between 8.0 and 8.5, and the following estimated substrate K,' s: 0.25 X lo-" M for propionyl CoA; 2.0 X M for bicarbonate; and 0.05 X M for ATP (7, 8, 12) . Despite having achieved only a partial purification of PCC from normal human fibroblasts, our results indicate that the human enzyme shares many similarities with its counterparts in other animal tissues. First, the human enzyme has a molecular weight comparable to that of the pig heart enzyme. Second, human PCC is avidin-inhibitable and this effect can be overcome by prior reaction of the avidin with biotin, indicating that human fibroblast PCC contains one or more biotin prosthetic groups. Third, it is activated by potassium and has K,' s for each of its three substrates which agree within an order of magnitude with those found for purified PCC's. Fourth, its pH optimum is very similar to that of the porcine and bovine enzyme.
Although PCC activity in cell lysates from each patient with propionic acidemia was less than 5% that found in control lines, invariably some residual enzyme activity was detectable. That this residual PCC activity does not merely reflect cross-carboxylation of propionyl CoA by a second, biotin-dependent enzyme, acetyl CoA carboxylase, (ACC) was established in two ways. First, citrate-activated ACC activity was lost from both wntrol and mutant cell lines during the ammonium sulfate treatment step, yet propionyl CoA carboxylation was enhanced by this purification procedure. Second, addition of anti-ACC antibody had no effect on residual PCC activity found in mutant lines whereas it inactivated much of the detectable ACC activity.
It could be argued that the residual PCC activity found in mutant cells reflects much reduced amounts of normal enzyme. The mutant enzyme was found in the same fractions during purification as the wntrol, was inhibited by avidin, had a similar sedimentation pattern upon density gradient centrifugation and had cornparable substrate K,' s to those of the normal enzyme. This thesis is refuted by two obseivations, however. First, mutant PCC was noted to be cold labile, while control enzyme was not.
This property led to major problems in storing and purifying the mutant enzyme. Second, mutant PCC was much more thermolabide than its normal counterpart. This lability was demonstrable in. partially purified fractions as well as crude extracts, thus appearing to be an intrinsic property of the mutant enzyme. Clearly, additional chemical and physical properties of the mutant enzyme must be studied to confirm the physical evidence just mentioned. Nonetheless, our findings lead us to conclude that PCC deficiency in the patients studied results from one or more mutations of the structural gene for PCC which lead, in turn, to structurally altered enzyme molecules whose affinity for substrates is comparable to that of controls, but whose in vivo stability is markedly impaired.
